S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment
Update: 2024-10-02
Description
John McKendry, President and CEO of KYE, gives insights into the importance of operating within regulations, leadership in pharma, and new treatment and delivery options for ADHD.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Comments
In Channel